Scarica l'app Stockscreener
0.31
4.10%
0.0122
Dopo l'orario di chiusura:
.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.2978
Aprire:
$0.29
Volume 24 ore:
1.05M
Relative Volume:
0.61
Capitalizzazione di mercato:
$12.85M
Reddito:
$1.50M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
-0.1856
EPS:
-1.67
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
+7.49%
1M Prestazione:
-13.82%
6M Prestazione:
-35.82%
1 anno Prestazione:
-88.60%
Intervallo 1D:
$0.29
$0.32
Intervallo di 1 settimana:
$0.26
$0.32
Portata 52W:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Nome
Leap Therapeutics Inc
Settore
Industria
Telefono
617 252 4343
Indirizzo
47 THORNDIKE STREET, CAMBRIDGE, MA
Confronta LPTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.31 | 11.95M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2021-10-04 | Iniziato | Mizuho | Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2020-06-29 | Iniziato | Piper Sandler | Overweight |
| 2020-02-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | Ripresa | Raymond James | Outperform |
| 2017-03-07 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Leap Therapeutics Inc Borsa (LPTX) Ultime notizie
What recovery options are there for Leap Therapeutics Inc.July 2025 Price Swings & High Conviction Trade Alerts - Newser
Relative strength of Leap Therapeutics Inc. in sector analysisQuarterly Profit Summary & Smart Allocation Stock Reports - Newser
How to escape a deep drawdown in Leap Therapeutics Inc.Weekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Does Leap Therapeutics Inc. show high probability of reboundJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Is it time to cut losses on Leap Therapeutics Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Does Leap Therapeutics Inc. fit your quant trading modelJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - Newser
Has Leap Therapeutics Inc. found a price floor2025 Top Gainers & High Accuracy Swing Trade Signals - Newser
What technical models suggest about Leap Therapeutics Inc.’s comebackWeekly Trade Report & Low Risk Investment Opportunities - Newser
What indicators show strength in Leap Therapeutics Inc.Trend Reversal & Daily Technical Forecast Reports - Newser
Published on: 2025-08-19 15:50:16 - Newser
News impact scoring models applied to Leap Therapeutics Inc.July 2025 Recap & Safe Capital Investment Plans - Newser
Pattern recognition hints at Leap Therapeutics Inc. upside2025 Price Action Summary & Weekly Market Pulse Alerts - Newser
What earnings revisions data tells us about Leap Therapeutics Inc.July 2025 Recap & Entry Point Confirmation Signals - Newser
Published on: 2025-08-19 04:14:39 - Newser
Chart overlay techniques for tracking Leap Therapeutics Inc.2025 Trading Recap & AI Forecast for Swing Trade Picks - Newser
How to recover losses in Leap Therapeutics Inc. stockJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
Leap Therapeutics Inc. Shows Early Signs of Technical Strength2025 Buyback Activity & Real-Time Volume Trigger Notifications - kangso.co.kr
LPTX Stock: A Comprehensive Analysis and Forecast - investchronicle.com
Leap Therapeutics Posts Q2 2025 Loss Amid High R&D Spend; Earnings Momentum Points to Long-Term Potential - AInvest
Applying Elliott Wave Theory to Leap Therapeutics Inc.Market Growth Report & Safe Swing Trade Setups - Newser
Leap Therapeutics Inc. stock retracement – recovery analysisWeekly Market Outlook & Weekly Stock Performance Updates - Newser
Does Leap Therapeutics Inc. stock pay reliable dividendsJuly 2025 Breakouts & Long-Term Safe Investment Ideas - Newser
Is Leap Therapeutics Inc. stock reversal real or fakeLayoff News & Growth Focused Stock Reports - Newser
Is Leap Therapeutics Inc. stock entering bullish territoryJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
Leap Therapeutics Posts Earnings Miss Amid Rising R&D Costs, But Historical Backtests Suggest Strong Post-Beat Momentum - AInvest
Is Leap Therapeutics Inc. exposed to political risk2025 Investor Takeaways & Free Verified High Yield Trade Plans - 선데이타임즈
Using data filters to optimize entry into Leap Therapeutics Inc.Gap Down & Verified Momentum Stock Watchlist - Newser
What data driven models say about Leap Therapeutics Inc.’s future2025 Geopolitical Influence & Proven Capital Preservation Methods - Newser
Top chart patterns to watch in Leap Therapeutics Inc.July 2025 Setups & Safe Capital Allocation Plans - Newser
When is the best time to exit Leap Therapeutics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Why Leap Therapeutics Inc. stock attracts strong analyst attentionQuarterly Portfolio Report & AI Enhanced Execution Alerts - Newser
Sector ETF performance correlation with Leap Therapeutics Inc.Quarterly Trade Review & Safe Entry Point Identification - Newser
How to monitor Leap Therapeutics Inc. with trend dashboards2025 Dividend Review & Free Real-Time Market Sentiment Alerts - Newser
Analyzing Leap Therapeutics Inc. with multi timeframe chartsOptions Play & Scalable Portfolio Growth Ideas - Newser
Leap Therapeutics (LPTX) Surges 11.95% on Intraday Rally – What’s Fueling the Biotech Breakout? - AInvest
Leap Therapeutics shares rise 2.46% premarket after reporting earnings results. - AInvest
Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):